NAT14 Antikörper (AA 5-33)
Quick Overview for NAT14 Antikörper (AA 5-33) (ABIN2625938)
Target
Alle NAT14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 5-33
-
Spezifität
- This NAT14 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 5-33 amino acids from the N-terminal region of human NAT14.
-
Aufreinigung
- Affinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: ELISA (1:1000), IHC (1:50 - 1:100), WB (1:100 - 1:500)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
-
-
- NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))
-
Andere Bezeichnung
- NAT14
-
Hintergrund
-
Name/Gene ID: NAT14
Synonyms: NAT14, KLP1, N-acetyltransferase 14 -
Gen-ID
- 57106
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-